dc.contributor.author |
Sabbagh A.S. |
dc.contributor.author |
Mahfoud Z. |
dc.contributor.author |
Taher A. |
dc.contributor.author |
Zaatari G. |
dc.contributor.author |
Daher R. |
dc.contributor.author |
Mahfouz R.A.R. |
dc.contributor.editor |
|
dc.date |
Mar-2008 |
dc.date.accessioned |
2017-10-05T15:59:46Z |
dc.date.available |
2017-10-05T15:59:46Z |
dc.date.issued |
2008 |
dc.identifier |
10.1089/gte.2007.0064 |
dc.identifier.isbn |
|
dc.identifier.issn |
10906576 |
dc.identifier.uri |
http://hdl.handle.net/10938/19234 |
dc.description.abstract |
Background: Mutations in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene could reduce the enzyme activity and lead to hyperhomocysteinemia, a condition that has been associated with several vascular conditions, in particular, coronary artery disease and deep vein thrombosis. Aim: The aim of this study was to assess the prevalence of the two most common polymorphisms, C677T and A1298C, which have not been well studied in the Lebanese population. Methods: We randomly selected 205 healthy individuals originating from different Lebanese provinces and religious communities. The CVD StripAssay was used to test for MTHFR gene polymorphisms. Results: We found that for C677T, the prevalence of C-C, C-T, and T-T genotypes was 65.3percent, 30.8percent, and 3.9percent, respectively, with an overall carrier rate of 34.6percent and allelic frequency of 0.19. However, the A1298C genotypic prevalence of A-C, A-A, and C-C was 50.2percent, 25.9percent, and 23.9percent, respectively, with an overall carrier rate of 74.14percent and an allelic frequency of 0.49. Conclusions: Compared to all other populations reported so far, the Lebanese population harbors the highest prevalence of the MTHFR A1298C polymorphism. This is an important finding to be followed in terms of clinical significance and sheds light on an additional unique genetic feature in this community. © Copyright 2008, Mary Ann Liebert, Inc. |
dc.format.extent |
|
dc.format.extent |
Pages: (75-80) |
dc.language |
English |
dc.publisher |
NEW ROCHELLE |
dc.relation.ispartof |
Publication Name: Genetic Testing; Publication Year: 2008; Volume: 12; no. 1; Pages: (75-80); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
High prevalence of MTHFR gene A1298C polymorphism in Lebanon |
dc.type |
Article |
dc.contributor.affiliation |
Sabbagh, A.S., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Mahfoud, Z., Department of Epidemiology and Population Health, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Taher, A., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Zaatari, G., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Daher, R., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Mahfouz, R.A.R., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon, Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon |
dc.contributor.authorAddress |
Mahfouz, R. A. R.; Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon; email: rm11@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pathology and Laboratory Medicine; |
dc.contributor.authorDepartment |
Pathology and Laboratory Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
rm11@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Sabbagh, AS |
dc.contributor.authorInitials |
Mahfoud, Z |
dc.contributor.authorInitials |
Taher, A |
dc.contributor.authorInitials |
Zaatari, G |
dc.contributor.authorInitials |
Daher, R |
dc.contributor.authorInitials |
Mahfouz, RAR |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Mahfouz, RAR (reprint author), Amer Univ Beirut, Med Ctr, Dept Pathol and Lab Med, POB 11-0236,Riad El Solh 1107 2020, Beirut, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Al-Habboubi H, 2003, J THROMB HAEMOST, V1, P2246, DOI 10.1046-j.1538-7836.2003.00390.x; Al-Habboubi HH, 2004, THROMB HAEMOSTASIS, V91, P843; Almawi WY, 2004, AM J HEMATOL, V76, P85, DOI 10.1002-ajh.20047; Angeline T, 2004, EXP MOL PATHOL, V77, P85, DOI 10.1016-j.yexmp.2004.04.006; Antoniadi T, 1999, AM J HEMATOL, V61, P265, DOI 10.1002-(SICI)1096-8652(199908)61:4265::AID-AJH83.0.CO;2-#; Arruda VR, 1998, AM J MED GENET, V78, P332, DOI 10.1002-(SICI)1096-8628(19980724)78:4332::AID-AJMG53.0.CO;2-N; Chango A, 2000, BRIT J NUTR, V84, P891; Chiusolo P, 2004, HAEMATOLOGICA, V89, P139; DAngelo A, 1997, HAEMATOLOGICA, V82, P211; DeFranchis R, 1996, AM J HUM GENET, V59, P262; De Marco P, 2002, J HUM GENET, V47, P319, DOI 10.1007-s100380200043; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056-NEJM199603213341203; Eid Suhair S, 2004, Clin Lab Sci, V17, P200; Esfahani ST, 2003, J AM DIET ASSOC, V103, P200, DOI 10.1053-jada.2003.50030; Falchi A, 2005, EXP MOL PATHOL, V79, P210, DOI 10.1016-j.yexmp.2005.09.005; Franco RF, 1998, THROMB HAEMOSTASIS, V79, P119; Friedman G, 1999, J NUTR, V129, P1656; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038-ng0595-111; Gibson CS, 2005, PATHOLOGY, V37, P160, DOI 10.1080-00313020500058250; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001-jama.277.22.1775; Gudnason V, 1998, ATHEROSCLEROSIS, V136, P347, DOI 10.1016-S0021-9150(97)00237-2; Hanson NQ, 2001, CLIN CHEM, V47, P661; Hiraoka M, 2004, BIOCHEM BIOPH RES CO, V316, P1210, DOI 10.1016-j.bbrc.2004.02.174; Kahleova R, 2002, AM J HYPERTENS, V15, P857, DOI 10.1016-S0895-7061(02)02984-9; KANG SS, 1991, AM J HUM GENET, V48, P536; Kiffmeyer WR, 2004, CANCER, V100, P411, DOI 10.1002-cncr.11913; Koch MC, 1998, EUR J PEDIATR, V157, P487, DOI 10.1007-s004310050860; Kostulas K, 1998, EUR J CLIN INVEST, V28, P285; Lu YH, 2002, THROMB RES, V106, P7, DOI 10.1016-S0049-3848(02)00064-6; Mahfouz RAR, 2006, MOL BIOL REP, V33, P145, DOI 10.1007-s11033-006-6260-x; Markan S, 2007, MOL CELL BIOCHEM, V302, P125, DOI 10.1007-s11010-007-9434-5; Mornet E, 1997, HUM GENET, V100, P512, DOI 10.1007-s004390050544; Mutchinick OM, 1999, MOL GENET METAB, V68, P461, DOI 10.1006-mgme.1999.2939; Nishio H, 1996, JPN J HUM GENET, V41, P247, DOI 10.1007-BF01875985; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002-(SICI)1096-8628(19960628)63:4610::AID-AJMG153.3.CO;2-Y; Peng FY, 2001, INT J MOL MED, V8, P509; Pepe G, 1998, AM J HUM GENET, V63, P917, DOI 10.1086-302015; Perez ABA, 2003, AM J MED GENET A, V119A, P20, DOI 10.1002-ajmg.a.10059; Rady PL, 1999, AM J MED GENET, V86, P380, DOI 10.1002-(SICI)1096-8628(19991008)86:4380::AID-AJMG133.0.CO;2-9; Rosenberg N, 2002, AM J HUM GENET, V70, P758, DOI 10.1086-338932; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; SABBAGH AS, 2006, MOL BIOL REP, V34, P47; Sacchi E, 1997, THROMB HAEMOSTASIS, V78, P963; Sazci A, 2005, CELL BIOCHEM FUNCT, V23, P51, DOI 10.1027-cbf.1132; Shrubsole MJ, 2004, CANCER EPIDEM BIOMAR, V13, P190, DOI 10.1158-1055-9965.EPI-03-0273; Stevenson RE, 1997, AM J HUM GENET, V60, P229; Taher A, 2001, THROMB HAEMOSTASIS, V86, P723; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086-301825; Vanegas OC, 1998, THROMB HAEMOSTASIS, V79, P883; Viel A, 1997, BRIT J CANCER, V75, P1105, DOI 10.1038-bjc.1997.191; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006-mgme.1998.2714; Wilcken DEL, 1996, ARTERIOSCL THROM VAS, V16, P878; Yoo JH, 2000, THROMB RES, V97, P77, DOI 10.1016-S0049-3848(99)00127-9; Zaatari GS, 2006, PATHOLOGY, V38, P442, DOI 10.1080-00313020600922934; Zetterberg H, 2002, THROMB RES, V108, P127, DOI 10.1016-S0049-3848(03)00004-5 |
dc.description.citedCount |
19 |
dc.description.citedTotWOSCount |
19 |
dc.description.citedWOSCount |
16 |
dc.format.extentCount |
6 |
dc.identifier.articleNo |
|
dc.identifier.coden |
GETEF |
dc.identifier.pubmedID |
18373406 |
dc.identifier.scopusID |
41449106682 |
dc.identifier.url |
|
dc.publisher.address |
140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Genet. Test. |
dc.relation.ispartOfIssue |
1 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Genetic Testing |
dc.relation.ispartofPubTitleAbbr |
Genet. Test. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
12 |
dc.source.ID |
WOS:000255019900010 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
|
dc.subject.otherChemCAS |
5,10 methylenetetrahydrofolate reductase (FADH2), 9028-69-7 |
dc.subject.otherChemCAS |
Methylenetetrahydrofolate Reductase (NADPH2), EC 1.5.1.20 |
dc.subject.otherIndex |
5,10 methylenetetrahydrofolate reductase (FADH2) |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
DNA polymorphism |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
gene frequency |
dc.subject.otherIndex |
gene mutation |
dc.subject.otherIndex |
genetic analysis |
dc.subject.otherIndex |
genotype |
dc.subject.otherIndex |
heterozygosity |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
prevalence |
dc.subject.otherIndex |
Alleles |
dc.subject.otherIndex |
Amino Acid Substitution |
dc.subject.otherIndex |
Ethnic Groups |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Gene Frequency |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Methylenetetrahydrofolate Reductase (NADPH2) |
dc.subject.otherIndex |
Point Mutation |
dc.subject.otherIndex |
Polymerase Chain Reaction |
dc.subject.otherIndex |
Polymorphism, Single Nucleotide |
dc.subject.otherKeywordPlus |
METHYLENETETRAHYDROFOLATE REDUCTASE GENE |
dc.subject.otherKeywordPlus |
NEURAL-TUBE DEFECTS |
dc.subject.otherKeywordPlus |
CORONARY-ARTERY-DISEASE |
dc.subject.otherKeywordPlus |
SINGLE NUCLEOTIDE POLYMORPHISMS |
dc.subject.otherKeywordPlus |
DIFFERENT ETHNIC-GROUPS |
dc.subject.otherKeywordPlus |
FACTOR-V-LEIDEN |
dc.subject.otherKeywordPlus |
5,10-METHYLENETETRAHYDROFOLATE REDUCTASE |
dc.subject.otherKeywordPlus |
C677T MUTATION |
dc.subject.otherKeywordPlus |
RISK-FACTOR |
dc.subject.otherKeywordPlus |
PLASMA HOMOCYSTEINE |
dc.subject.otherWOS |
Genetics and Heredity |
dc.subject.otherWOS |
Medicine, Research and Experimental |